US · EVMN
Evommune, Inc.
- Sector
- Healthcare · Biotechnology
- Headquarters
- Palo Alto, CA 94304
- Website
- evommune.com
Price at previous close
$12.96
Market cap 322.66M
Price history
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | $0.00 | $0.00 | |||
| 2025 | $0.00 | $0.00 |
USD millions
Line items
USD millions
Line items
USD millions
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| EVMN | Evommune, Inc. | $12.96 | 322.66M | — | — | — | — | — | — | — | — | — |
| ARTV | Artiva Biotherapeutics, I… | $7.61 | 188.09M | +233% | -37% | — | +2,637% | -2.00 | 0.70 | 520.26 | 0.62 | -9925.00% |
| CDXS | Codexis, Inc. | $2.75 | 249.97M | — | — | — | — | — | — | — | — | — |
| CLYM | Climb Bio, Inc. | $11.34 | 773.21M | — | — | — | — | -0.96 | 0.33 | — | 2.62 | — |
| EYPT | EyePoint Pharmaceuticals,… | $13.50 | 1.13B | — | — | — | +329% | — | — | — | — | — |
| FTRE | Fortrea Holdings Inc. | $15.00 | 1.42B | -28% | -66% | — | — | -0.98 | 1.71 | 0.35 | -1.05 | 100.00% |
| GLPG | Galapagos N.V. | $28.39 | 1.87B | +315% | +508,368% | +200% | +5,842% | 6.01 | 0.60 | 1.73 | -1.90 | 30348.00% |
| KPTI | Karyopharm Therapeutics I… | $9.11 | 77.77M | +81% | -58% | — | — | -0.53 | -0.36 | 0.72 | -3.04 | 57.00% |
| LGND | Ligand Pharmaceuticals In… | $234.66 | 4.7B | +48% | -51% | -66% | +81% | 31.47 | 3.85 | 14.61 | 22.87 | 6040.00% |
| OABI | OmniAb, Inc. | $2.72 | 323.93M | — | — | — | +315% | — | — | — | — | — |
| ZYME | Zymeworks Inc. | $25.48 | 1.87B | — | — | — | — | — | — | — | — | — |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $12.96) − 1 = — (DCF, example).